These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
234 related items for PubMed ID: 28370885
1. Mortality Effect of ICD in Primary Prevention of Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Luni FK, Singh H, Khan AR, Malik SA, Khawaja O, Riaz H, Lee W, Kabour A, Richards M, Aasbo J. J Cardiovasc Electrophysiol; 2017 May; 28(5):538-543. PubMed ID: 28370885 [Abstract] [Full Text] [Related]
2. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis. Akel T, Lafferty J. Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469 [Abstract] [Full Text] [Related]
3. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials. Stavrakis S, Asad Z, Reynolds D. J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104 [Abstract] [Full Text] [Related]
4. Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy. Cavalcanti R, Aboul-Hosn N, Morales G, Abdel-Latif A. Angiology; 2018 Apr; 69(4):297-302. PubMed ID: 28554215 [Abstract] [Full Text] [Related]
6. Clinical impact of implantable cardioverter-defibrillator in primary prevention of total mortality in non-ischaemic cardiomyopathy: results from a meta-analysis of prospective randomized clinical trials. Romero J, Díaz JC, Grushko M, Quispe R, Briceno D, Avendano R, Golive A, Pina I, Natale A, Garcia MJ, Jorde UP, Di Biase L. Europace; 2018 Sep 01; 20(FI2):f211-f216. PubMed ID: 29161424 [Abstract] [Full Text] [Related]
7. Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure. Elming MB, Nielsen JC, Haarbo J, Videbæk L, Korup E, Signorovitch J, Olesen LL, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Køber L, Thune JJ. Circulation; 2017 Nov 07; 136(19):1772-1780. PubMed ID: 28877914 [Abstract] [Full Text] [Related]
18. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality. Fallavollita JA, Dare JD, Carter RL, Baldwa S, Canty JM. Circ Cardiovasc Imaging; 2017 Aug 01; 10(8):. PubMed ID: 28794139 [Abstract] [Full Text] [Related]
19. Primary prevention with a defibrillator: are therapies always really optimized before implantation? Foucault A, Amelot M, Gomes S, Champ-Rigot L, Saloux E, Pellissier A, Labombarda F, Scanu P, Milliez P. Europace; 2012 Nov 01; 14(11):1572-7. PubMed ID: 22696518 [Abstract] [Full Text] [Related]
20. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials. Wolff G, Lin Y, Karathanos A, Brockmeyer M, Wolters S, Nowak B, Fürnkranz A, Makimoto H, Kelm M, Schulze V. Clin Res Cardiol; 2017 Jul 01; 106(7):501-513. PubMed ID: 28213711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]